Navigation Links
Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
Date:5/17/2013

tion in Major Depression in People With or Without Baseline Executive Function Impairment"

Presenter: Andrew Cutler , MD

  • Monday, May 20, 2013; 2:00pm - 4:00pm

Poster #NR9-30: "Lisdexamfetamine Dimesylate Augmentation Therapy in Anxious or Nonanxious Major Depressive Disorder"

Presenter: Bryan Dirks , MD

  • Monday, May 20, 2013; 2:00pm - 4:00pm

Poster #NR9-38: "Post Hoc Analysis of Lisdexamfetamine Dimesylate Augmentation Therapy Effects on Sleep-Related Endpoints in Adults With Major Depressive Disorder"

Presenter: Angelo Sambunaris , MD

Guanfacine Extended Release (Health Economics and Outcomes Research)

  • Monday, May 20, 2013; 11:30pm - 1:00pm

Poster #NR8-51: "Period Prevalence of Stimulant Augmentation Among Adolescents With ADHD in a U.S. Managed Care Population During 2009 and 2010"

Presenter: Vanja Sikirica , PharmD, MPH

ADHD Outcomes Research

  • Monday, May 20, 2013; 11:30am - 1:00pm

Poster #NR8-29: "Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder (ADHD): A Systematic Review of Self Esteem and Social Functioning"

Presenter: Paul Hodgkins , PhD

ABOUT VYVANSE (lisdexamfetamine dimesylate)

Vyvanse, which was introduced in the United States in July 2007 for the treatment of ADHD in children ages 6 to 12 years, approved in April 2008 to treat ADHD in adults, approved in November 2010 to treat ADHD in adolescents ages 13 to 17, approved in January 2012 for maintenance treatment in adults, and approved in April 2013 for maintenance tr
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
4. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
5. Shire Second Quarter Product Sales Up 16%
6. Dr Steven Gillis to Join Shire Board of Directors
7. Shire Leads New Initiative to Reveal Challenges Facing Rare Disease Community
8. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
9. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
10. Shire Delivers Strong 2012 Results and Reiterates Confidence in 2013
11. Shire Supports Rare Disease Day 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  July 4 th is this ... and the spirit and people behind it. To help honor ... with USA Medical Card, a leading ... for programs that empower independence for our disabled military veterans, ... more people afford their prescriptions. "Due to ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
(Date:6/29/2015)... -- Mordor Intelligence presents their Global Pharmaceutical ... Glass, Paper, Metal) - ByType of Packaging (Ampules, Blister Packs, ... Sachets) - By Geographical Region ( North America ... , Latin America , ... - discussing Industry Value Chain Analysis, Porter,s 5 Force Analysis, ...
Breaking Medicine Technology:Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... SAN FRANCISCO, May 6 Medizone (Pink Sheets: ... the first in a series of trials designed ... System can rapidly eliminate hospital-based bacterial pathogens known ... deaths and serious infections currently plaguing the healthcare ...
... BioTechnologies, Inc. (TriLink), a leading provider of custom ... Start PCR reagent - CleanAmp(TM) dNTPs.CleanAmp(TM) dNTPs offer ... PCR results. Using CleanAmp(TM) dNTPs allows precise ... by blocking DNA polymerase nucleotide incorporation until heat ...
Cached Medicine Technology:Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun 2
(Date:6/30/2015)... , ... June 30, 2015 , ... The American Lung ... at a media event in San Diego. Speakers and clean air advocates included San ... medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder and president of Sullivan ...
(Date:6/30/2015)... ... June 30, 2015 , ... According to a June 15th ... grant to study how sensory stimuli can be used to “decrease children’s anxiety and ... for children with autism, will compare patient experience in a “typical dental environment” with ...
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... ... when buying eyeglasses online , finally its here, http://www.express-glasses.com ... express shipping rates, for many location, ask about shipping with DHL Express when ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM supplier ... added a new CEO, Mr. Darold Francis. The changes will help enhance the company’s ... that customers have come to know and respect for over eight years. , “I ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates today ... Healthcare Research & Analytics , a consultative healthcare market research practice that is ... businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research services ...
Breaking Medicine News(10 mins):Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3
... public, even families are involved, study finds , FRIDAY, ... family history of an incurable genetic disease isn,t worry ... report being discriminated against by insurance companies, relatives and ... Yvonne Bombard and colleagues at the University of British ...
... Children,s Hospital, Summit County ... to provide full-range of services to families with children who have ... Copley Township , , FAIRLAWN, Ohio, ... creation of the Robert J. Keegan Family Center for Autism. , , ...
... Denmark, Friday 12 June 2009: First line treatment with ... ,good, clinical response (ACRp90) in patients newly diagnosed with ... deficient IL-18 response of natural killer (NK) cells*, according ... a joint congress with the 2009 Congress of the ...
... June 2009: Three new studies have individually shown the ... with a good safety profile, in children under four ... associated with improved Health-Related Quality of Life (HRQoL) in ... are being presented at the Paediatric Rheumatology European Society ...
... Denmark, Friday 12 June 2009: Over half (56%) of ... chronic inflammatory disease of the gum and surrounding ligaments ... fewer teeth than healthy matched controls, high prevalence of ... (the extent of periodontal support that has been destroyed ...
... frailty stand to benefit from the first potential ... study presented today by Penn Medicine researchers at ... Ghrelin, a hormone that stimulates appetite, was administered ... geriatric syndrome characterized by unintentional weight loss, weakness, ...
Cached Medicine News:Health News:People With Huntington's Report Discrimination 2Health News:People With Huntington's Report Discrimination 3Health News:Autism Family Foundation Introduces The Robert J. Keegan Family Center for Autism 2Health News:Autism Family Foundation Introduces The Robert J. Keegan Family Center for Autism 3Health News:Early treatment of systemic onset JIA with anakinra restores the IL-18 response 2Health News:3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis 2Health News:3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis 3Health News:3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis 4Health News:Over half of people with rheumatoid arthritis have periodontitis 2Health News:Over half of people with rheumatoid arthritis have periodontitis 3Health News:Appetite-stimulating hormone is first potential medical treatment for frailty in older women 2
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: